Literature DB >> 24886012

Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment.

Deanna M Barch1, Michael T Treadway2, Nathan Schoen1.   

Abstract

One of the most debilitating aspects of schizophrenia is an apparent interest in or ability to exert effort for rewards. Such "negative symptoms" may prevent individuals from obtaining potentially beneficial outcomes in educational, occupational, or social domains. In animal models, dopamine abnormalities decrease willingness to work for rewards, implicating dopamine (DA) function as a candidate substrate for negative symptoms given that schizophrenia involves dysregulation of the dopamine system. We used the effort-expenditure for rewards task (EEfRT) to assess the degree to which individuals with schizophrenia were wiling to exert increased effort for either larger magnitude rewards or for rewards that were more probable. Fifty-nine individuals with schizophrenia and 39 demographically similar controls performed the EEfRT task, which involves making choices between "easy" and "hard" tasks to earn potential rewards. Individuals with schizophrenia showed less of an increase in effort allocation as either reward magnitude or probability increased. In controls, the frequency of choosing the hard task in high reward magnitude and probability conditions was negatively correlated with depression severity and anhedonia. In schizophrenia, fewer hard task choices were associated with more severe negative symptoms and worse community and work function as assessed by a caretaker. Consistent with patterns of disrupted dopamine functioning observed in animal models of schizophrenia, these results suggest that 1 mechanism contributing to impaired function and motivational drive in schizophrenia may be a reduced allocation of greater effort for higher magnitude or higher probability rewards.

Entities:  

Mesh:

Year:  2014        PMID: 24886012      PMCID: PMC4048870          DOI: 10.1037/a0036299

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  58 in total

1.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

Review 2.  The mysterious motivational functions of mesolimbic dopamine.

Authors:  John D Salamone; Mercè Correa
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

3.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

4.  Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.

Authors:  Alexandra Soliman; Gillian A O'Driscoll; Jens Pruessner; Anne-Lise V Holahan; Isabelle Boileau; Danny Gagnon; Alain Dagher
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

Review 5.  Dopamine modulates neural networks involved in effort-based decision-making.

Authors:  Seyed M Assadi; Murat Yücel; Christos Pantelis
Journal:  Neurosci Biobehav Rev       Date:  2008-11-13       Impact factor: 8.989

6.  Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia.

Authors:  Katiah Llerena; Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Res       Date:  2012-10-03       Impact factor: 4.939

7.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

8.  Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.

Authors:  Ryan D Ward; Eleanor H Simpson; Vanessa L Richards; Gita Deo; Kathleen Taylor; John I Glendinning; Eric R Kandel; Peter D Balsam
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

Review 9.  Multiple dopamine functions at different time courses.

Authors:  Wolfram Schultz
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

10.  Prefrontal dopamine and behavioral flexibility: shifting from an "inverted-U" toward a family of functions.

Authors:  Stan B Floresco
Journal:  Front Neurosci       Date:  2013-04-19       Impact factor: 4.677

View more
  98 in total

Review 1.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

3.  Emotional content impacts how executive function ability relates to willingness to wait and to work for reward.

Authors:  Katherine S F Damme; Nicholas J Kelley; Meghan E Quinn; James E Glazer; Iris Ka-Yi Chat; Katherine S Young; Robin Nusslock; Richard Zinbarg; Susan Bookheimer; Michelle G Craske
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

4.  Methylphenidate increases willingness to perform effort in adults with ADHD.

Authors:  Merideth A Addicott; Julia C Schechter; Jeffrey J Sapyta; James P Selig; Scott H Kollins; Margaret D Weiss
Journal:  Pharmacol Biochem Behav       Date:  2019-06-18       Impact factor: 3.533

5.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

6.  Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.

Authors:  Marta Pardo; Laura López-Cruz; Noemí San Miguel; John D Salamone; Mercè Correa
Journal:  Psychopharmacology (Berl)       Date:  2015-02-03       Impact factor: 4.530

Review 7.  Effort cost computation in schizophrenia: a commentary on the recent literature.

Authors:  James M Gold; James A Waltz; Michael J Frank
Journal:  Biol Psychiatry       Date:  2015-05-11       Impact factor: 13.382

8.  Impaired effort allocation in patients with schizophrenia.

Authors:  Michael T Treadway; Joel S Peterman; David H Zald; Sohee Park
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

9.  Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost.

Authors:  Alexandre Zénon; Sophie Devesse; Etienne Olivier
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

Review 10.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.